Mildred K. Buening

1.6k citations

26 papers · 1.3k indexed · h-index 17

Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism 5
- Antibiotics Pharmacokinetics and Efficacy 3
- Cannabis and Cannabinoid Research 2
Cancer Research top 5%
- Carcinogens and Genotoxicity Assessment 3
- Cancer, Hypoxia, and Metabolism 3
Biochemistry top 5%
- Eicosanoids and Hypertension Pharmacology 7
Biochemistry top 10%
- Eicosanoids and Hypertension Pharmacology 7
Health, Toxicology and Mutagenesis top 10%
Organic Chemistry
- Click Chemistry and Applications 2
Cell Biology
- Aldose Reductase and Taurine 2

Co-authors: Allan H. Conney Joseph G. Fortner Wayne Levin Alexander W. Wood Richard L. Chang Haruhiko Yagi M R Franklin Dhiren R. Thakker
Cited by: Pharmacology Cancer Research Biochemistry
Journals: Proceedings of the National Academy of Sciences (1 paper)The Lancet (1 paper)Journal of Biological Chemistry (1 paper)
Partner nations: United States Switzerland

In The Last Decade

Mildred K. Buening

26 papers receiving 1.2k citations

Peers

Countries citing papers authored by Mildred K. Buening

Since Specialization

Citations

This map shows the geographic impact of Mildred K. Buening's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mildred K. Buening with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mildred K. Buening more than expected).

Fields of papers citing papers by Mildred K. Buening

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mildred K. Buening. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mildred K. Buening. The network helps show where Mildred K. Buening may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mildred K. Buening, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mildred K. Buening Line = papers co-authored together Mildred K. Buening links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Developmental Toxicology Studies of Vancomycin Hydrochloride Administered Intravenously to Rats and Rabbits Toxicological Sciences ·Richard A. Byrd,Christian L. Gries,Mildred K. Buening	1994	2
2	General pharmacology of loracarbef in animals. PubMed ·T Shetler,A.M. Bendele,Mildred K. Buening,James A. Clemens,Walter E. Colbert,Ahmed Deldar,David R. Helton,J.C. McGrath,H E Shannon,J Turk	1993	2
3	Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles Antimicrobial Agents and Chemotherapy ·Walter E. Colbert,John A. Turk,Patricia D. Williams,Mildred K. Buening	1991	6
4	Comparative toxicity of oral cephalosporin antibiotics in the rabbit and in a rabbit kidney cell line (LLC-RK1) Toxicology in Vitro ·Patricia D. Williams,Mildred K. Buening,Christian L. Gries,G. K. Hanasono,Dennis A. Laska,R. Tamura,Roger Heim	1990	4
5	Fluorine Substitution as a Probe for the Role of the 6-Position of Benzo[<italic>a</italic>]pyrene in Carcinogenesis<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref> JNCI Journal of the National Cancer Institute ·Mildred K. Buening,Wayne Levin,Alexander W. Wood,Richard L. Chang,Israel Agranat,Mordecai Rabinovitz,Donald R. Buhler,He Duck Mah,Óscar Hernández,R. B. Simpson,Donald M. Jerina,A. H. Conney,E. C. Miller,James A. Miller	1983	15
6	Ethanol-Moxalactam Interactions in Vivo Clinical Infectious Diseases ·Mildred K. Buening,John S. Wold	1982	24
7	An enantiomeric interaction in the metabolism and tumorigenicity of (+)- and (-)-benzo[a]pyrene 7,8-oxide. Journal of Biological Chemistry ·Wayne Levin,Mildred K. Buening,Alexander W. Wood,Richard L. Chang,Bogdan Kedzierski,Dhiren R. Thakker,Derek R. Boyd,Guru S. Gadaginamath,Richard N. Armstrong,Haruhiko Yagi,Jean M. Karle,T.J. Slaga,D. M. JERINA,Allan H. Conney	1980	61
8	Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice. PubMed ·Mildred K. Buening,Wayne Levin,Alexander W. Wood,Richard L. Chang,Roland E. Lehr,Charles W. Taylor,Haruhiko Yagi,Donald M. Jerina,Allan H. Conney	1980	14
9	Regulation of Human Drug Metabolism by Dietary Factors Novartis Foundation symposium ·Allan H. Conney,Mildred K. Buening,Eugene J. Pantuck,Carol B. Pantuck,Joseph G. Fortner,Karl E. Anderson,Attallah Kappas	1980	29
10	Tumorigenicity of bay-region epoxides and other derivatives of chrysene and phenanthrene in newborn mice. PubMed ·Mildred K. Buening,Wayne Levin,Jean M. Karle,Haruhiko Yagi,Donald M. Jerina,Allan H. Conney	1979	32
11	Tumorigenicity of the Diastereomeric Benz[<italic>a</italic>]anthracene 3,4-Diol-1,2-epoxides and the (+)- and (−)-Enantiomers of Benz[<italic>a</italic>]anthracene 3,4-Dihydrodiol in Newborn Mice JNCI Journal of the National Cancer Institute ·Peter G. Wislocki,Mildred K. Buening,Wayne Levin,Roland E. Lehr,Dhiren R. Thakker,Donald M. Jerina,Allan H. Conney	1979	25
12	Tumorigenicity of the dihydrodiols of dibenzo(a,h)anthracene on mouse skin and in newborn mice. PubMed ·Mildred K. Buening,Wayne Levin,Alexander W. Wood,Richard L. Chang,Haruhiko Yagi,Jean M. Karle,Donald M. Jerina,Allan H. Conney	1979	21
13	Metabolism of trans-9,10-Dihydroxy-9,10-dihydrobenzo[a]pyrene Occurs Primarily by Arylhydroxylation Rather than Formation of a Diol Epoxide Molecular Pharmacology ·Dhiren R. Thakker,Haruhiko Yagi,Roland E. Lehr,Wayne Levin,Mildred K. Buening,Albert Lu,Richard L. Chang,Alexander W. Wood,Allan H. Conney,D. M. JERINA	1978	37
14	Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proceedings of the National Academy of Sciences ·Mildred K. Buening,Peter G. Wislocki,Wayne Levin,Haruhiko Yagi,Dhiren R. Thakker,H. Akagi,Masato Koreeda,D. M. JERINA,Allan H. Conney	1978	334
15	7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver Biochemical and Biophysical Research Communications ·Mildred K. Buening,Joseph G. Fortner,Attallah Kappas,Allan H. Conney	1978	54
16	Activation of monooxygenases in human liver by 7,8‐benzoflavone Clinical Pharmacology & Therapeutics ·Jaime Kapitulnik,P. J. Poppers,Mildred K. Buening,Joseph G. Fortner,Allan H. Conney	1977	53
17	The formation of cytochrome P-450-metabolic intermediate complexes in microsomal fractions from extrahepatic tissues of the rabbit. Drug Metabolism and Disposition ·Mildred K. Buening,M R Franklin	1976	11
18	THE FORMATION OF COMPLEXES ABSORBING AT 455 NM FROM CYTOCHROME P-450 AND METABOLITES OF COMPOUNDS RELATED TO SKF 525-A Drug Metabolism and Disposition ·Mildred K. Buening,MICHAEL R. FRANKLIN	1974	7
19	Limitations in the Use of the 340 nm Absorbance Maximum of Reduced Nicotinamide Adenine Dinucleotide Phosphate for the Determination of Oxidation Rates and Stoichiometry during Rat Hepatic Microsomal Metabolism Molecular Pharmacology ·Mildred K. Buening,Michael R. Franklin	1974	14
20	The formation of complexes absorbing at 455 nm from cytochrome P-450 and metabloites of compounds related to SKF 525-A. PubMed ·Mildred K. Buening,Michael R. Franklin	1974	33

About Mildred K. Buening

Mildred K. Buening is a scholar working on Biochemistry, Pharmacology and Pharmacology, having authored 26 papers that have together received 1.3k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (7 papers), Pharmacogenetics and Drug Metabolism (5 papers), Carcinogens and Genotoxicity Assessment (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Click Chemistry and Applications (2 papers), Aldose Reductase and Taurine (2 papers) and Cannabis and Cannabinoid Research (2 papers). The work is most often cited by research in Pharmacology (490 citations), Cancer Research (329 citations) and Biochemistry (142 citations). Mildred K. Buening has collaborated with scholars based in United States and Switzerland. Frequent co-authors include Allan H. Conney, Joseph G. Fortner, Wayne Levin, Alexander W. Wood, Richard L. Chang, Haruhiko Yagi, M R Franklin, Dhiren R. Thakker, D. M. JERINA and Mou‐Tuan Huang. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact